Continuum Advisory’s Edwards Lifesciences EW Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-455	Closed	-$33K	–	765
2025 Q1	$33K	Sell	455 -47	-9%	-$3.36K	﹤0.01%	764
2024 Q4	$37.2K	Sell	502 -153	-23%	-$10.7K	﹤0.01%	723
2024 Q3	$43.3K	Sell	655 -69	-10%	-$5.01K	0.01%	684
2024 Q2	$66.9K	Buy	724 +2	+0.3%	+$177	0.01%	564
2024 Q1	$63.1K	Buy	+722	New	+$60.6K	0.01%	565
2023 Q4	–	Sell	-5,560	Closed	-$385K	–	460
2023 Q3	$385K	Sell	5,560 -594	-10%	-$47.7K	0.06%	320
2023 Q2	$581K	Buy	6,154 +76	+1%	+$6.61K	0.09%	259
2023 Q1	$503K	Sell	6,078 -45	-0.7%	-$3.54K	0.09%	264
2022 Q4	$457K	Sell	6,123 -164	-3%	-$12.6K	0.08%	273
2022 Q3	$519K	Sell	6,287 -418	-6%	-$40.2K	0.09%	229
2022 Q2	$638K	Sell	6,705 -13	-0.2%	-$1.35K	0.12%	216
2022 Q1	$711K	Sell	6,718 -317	-5%	-$35.6K	0.14%	190
2021 Q4	$911K	Sell	7,035 -50	-0.7%	-$5.83K	0.2%	114
2021 Q3	$802K	Sell	7,085 -76	-1%	-$8.68K	0.21%	110
2021 Q2	$742K	Buy	+7,161	New	+$675K	0.23%	103